Search

The post-weaning social environment has profound effects on behavior and physiology in rodents. Social isolation increases anxiety-like behaviors and novelty-induced locomotor activity, while environmental enrichment decreases these behaviors. In some cases, the effects of social isolation are ameliorated by repeated handling. The goal of the present study was to determine whether the effects of handling differ in rats reared in social isolation and those reared in an enriched environment. After weaning, male Long-Evans rats were housed individually (ISO)(3) or in groups in an enriched environment (EE). During adulthood, rats from each housing condition received four, once-daily, brief handling sessions or remained undisturbed in the home cage. All rats were then tested in the open field, elevated plus maze, and for behavioral responses to d-amphetamine (1.0mg/kg). EE rats spent more time on the open arms of the elevated plus maze and were more likely than ISO rats to emerge from the start box in the open field, suggesting lower anxiety. Handling significantly decreased open arm time in EE rats and marginally increased open arm time in ISO rats. Housing condition did not affect amphetamine-stimulated locomotor activity, but handling altered the time course of the amphetamine response. ISO rats exhibited significantly fewer stereotyped behaviors than did EE rats, but repeated handling eliminated this difference. These findings support previously published studies that suggest brief handling of adult rats may at least partially ameliorate the effects of post-weaning social isolation on anxiety-like behaviors and psychostimulant sensitivity. Furthermore, there are complex interactions between the effects of housing environment and handling, suggesting that handling may be perceived and/or processed differently, depending on the animal's housing environment., (Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.)

In the central nervous system, angiotensin II (AngII) binds to angiotensin type 1 receptors (AT(1)Rs) to affect autonomic and endocrine functions as well as learning and memory. However, understanding the function of cells containing AT(1)Rs has been restricted by limited availability of specific antisera, difficulties discriminating AT(1)R-immunoreactive cells in many brain regions and, the identification of AT(1)R-containing neurons for physiological and molecular studies. Here, we demonstrate that an Agtr1a bacterial artificial chromosome (BAC) transgenic mouse line that expresses type A AT(1)Rs (AT1aRs) identified by enhanced green fluorescent protein (EGFP) overcomes these shortcomings. Throughout the brain, AT1aR-EGFP was detected in the nuclei and cytoplasm of cells, most of which were neurons. EGFP often extended into dendritic processes and could be identified either natively or with immunolabeling of GFP. The distribution of AT1aR-EGFP cells in brain closely corresponded to that reported for AngII binding and AT1aR protein and mRNA. In particular, AT1aR-EGFP cells were in autonomic regions (e.g., hypothalamic paraventricular nucleus, central nucleus of the amygdala, parabrachial nucleus, nuclei of the solitary tract and rostral ventrolateral medulla) and in regions involved in electrolyte and fluid balance (i.e., subfornical organ) and learning and memory (i.e., cerebral cortex and hippocampus). Additionally, dual label electron microscopic studies in select brain areas demonstrate that cells containing AT1aR-EGFP colocalize with AT(1)R-immunoreactivity. Assessment of AngII-induced free radical production in isolated EGFP cells demonstrated feasibility of studies investigating AT1aR signaling ex vivo. These findings support the utility of Agtr1a BAC transgenic reporter mice for future studies understanding the role of AT(1)R-containing cells in brain function., (Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.)

Piglets are highly susceptible to gut health-related problems. Intravenously administered chenodeoxycholic acid (CDCA) affects gut health mediated through glucagon-like peptide 2 (GLP-2). To test whether CDCA is a suitable feed additive for improving gut health, a trial was performed with newly weaned (21 d) piglets offered a diet with or without 60 mg CDCA/kg feed (n = 24/treatment). Upon weaning, piglets were fasted for 16 h and then intragastrically dosed with 20 g test feed in 40 g water. Subsequently, a jugular blood sample was taken on 45, 90, 135, or 180 min for analysis of GLP-2, peptide YY (PYY), and glucose. Afterwards, piglets were offered the experimental diets ad libitum. On days 3.5, 7.5, and 10.5 after weaning, serum responses to an intragastric dose of lactulose and Co-EDTA were tested at 2 h after dosing in 8 piglets per treatment. Immediately thereafter, piglets were euthanized, intestines were harvested, and permeability was measured ex vivo using the everted gut sac technique with 4 kDa fluorescein isothiocyanato (FITC)-dextran as marker at 25, 50, and 75% of the length of the small intestine. Dietary CDCA did not affect (P > 0.05) ADFI, ADG, G:F, blood glucose, and plasma GLP-2 and PYY. Serum cobalt and lactulose at day 10.5 tended to be lower in CDCA pigs compared with control pigs. Serum cobalt and lactulose concentrations were positively correlated (r = 0.67; P < 0.01). In conclusion, CDCA tended to reduce intestinal permeability at 10.5 d after weaning when fed to newly weaned piglets, implying that CDCA deserves further study as a means for improving intestinal health. The positive correlation found between Co-EDTA and lactulose indicates that both marker molecules measure similar change in permeability.

A neonatal piglet model was used to study hepatic fatty acid metabolism during the early postnatal period. Hepatocytes were isolated from pigs at birth or after 24 h, in fed or unfed states (n = 4 pigs/group). Cells were incubated with 1 mmol/L [1-(14)C]-octanoate (C8) or -palmitate (C16) in the presence or absence of 1 mmol/L L-carnitine, carnitine plus tetradecylglycidic acid (TDGA; 10 mumol/L) or carnitine plus glucagon (0.5 microgram/L). Accumulation of radiolabel [nmol/(h. 10(6) cells)] in CO2 and acid-soluble products (ASP) was higher (3.5- and 4.5-fold, respectively) from C8 than from C16 (P < 0.0001). Glucagon, carnitine and TDGA had no effect on the oxidation of C8 (P > 0.1). Carnitine addition tended to increase C16 flux to ASP [from 5.3 to 7.6 nmol/(h. 10(6) cells); P < 0.1], whereas carnitine plus TDGA decreased flux (from 7.6 to 2.1; P < 0.001). Esterified products accounted for 70% of metabolized label in control C16 incubations; this was reduced to 62% by carnitine (P < 0.05) and increased to 80% by the addition of carnitine plus TDGA (P < 0.0001). The 1-(14)C flux to CO2 in cells from 24-h-old unfed piglets was 47% lower than from fed pigs (P < 0.01) but 28% higher than in pigs at birth. Radiolabel contained in ASP and total metabolized label were 48% lower from unfed pigs compared with the piglets at birth and 24-h-old fed pigs (P < 0.01) and were paralleled by changes in oxygen consumption.(ABSTRACT TRUNCATED AT 250 WORDS)

Newborn, colostrum-deprived piglets (n = 21) were used to study the effects of L-carnitine supplementation on the in vivo oxidation of [1-14C]octanoate to CO2 and dicarboxylic acids. Pigs were fitted with arterial and bladder catheters and were infused with octanoate (supplying 35-100% of piglets' energy expenditure) and with or without valproate for a period of 24 h. After achieving steady-state octanoate oxidation, carnitine was coinfused [50 mumol/kg 0.75 prime plus 20 mumol/h.kg 0.75)], and deviations in the octanoate oxidation rate, dicarboxylic acid excretion rate, and carnitine metabolism were monitored. At the end of the 24-h infusion, samples of liver and muscle were analyzed for carnitine- and CoA-esters by HPLC. Carnitine stimulated octanoate oxidation by 7% (P < 0.05) and decreased dicarboxylic acid excretion by 45% (P < 0.05). Carnitine supplementation increased (P < 0.05) concentrations of carnitine and acetyl carnitine in hepatic tissue (three- and 55-fold, respectively) and plasma (seven- and 11-fold); whereas, muscle-carnitine concentration doubled upon carnitine supplementation, but acetyl carnitine concentration remained unaltered. Urinary excretion of acetyl and free carnitine also increased with carnitine supplementation, but accounted for < 10% of carnitine infused. Hepatic total CoA and CoA esters increased with carnitine supplementation, whereas muscle acetyl-CoA decreased. Valproate had only marginal effects on octanoate metabolism. These data confirm the hypothesis that carnitine effects the in vivo oxidation of octanoate in colostrum-deprived piglets and suggest that the effects may be mediated by aiding the export of excess acetyl groups from muscle or by enhancing uptake of octanoate into liver mitochondria.

In vivo oxidation kinetics of medium-chain triglycerides (MCT) composed of [1-14C]hexanoate (tri-6:0) or [1-14C]octanoate (tri-8:0) were compared after being fed to day-old piglets (1.4 kg; n = 4/treatment). Animals were fitted with arterial and oro-gastric catheters and placed into respiration chambers held at 35 degrees C. The radiolabeled MCT were fed in equimolar amounts (6.5 mmol/kg0.75), in either nonemulsified form or as 30% (v/v) emulsions, using polyoxyethylene sorbitan monooleate as an emulsifier. Expired CO2 was quantified and specific radioactivity (Bq/mumol) determined at 20-min intervals over 24 h, and serial blood samples were drawn for measurement of plasma hexanoate and octanoate by HPLC. The rate [mumol/(h.kg0.75)] and extent (mmol/kg0.75) of MCT oxidative utilization (i.e., composite of digestion, absorption and oxidation) were calculated from the kinetics of 14CO2 expiration. Emulsification increased both the rate and extent of MCT oxidative utilization by > 20% regardless of fatty acid chain length (P < 0.05). Maximal MCT oxidation rates occurred at 3.5 h after feeding and were sufficient to meet up to 48% of the piglets' energy expenditure. The maximal rate of tri-6:0 oxidative utilization exceeded that of tri-8:0 by 37% (P < 0.05), but the extent of utilization was not affected by fatty acid chain length. Plasma medium-chain fatty acid concentrations were in agreement with these observations, being higher in pigs fed emulsified MCT than in pigs fed nonemulsified MCT (P < 0.05) and being higher in pigs fed tri-6:0 than in animals fed tri-8:0 (P < 0.05). Collectively, these data demonstrate that newborn piglets can effectively digest, absorb and oxidize MCT, that utilization is improved with emulsification, and that tri-6:0 is utilized more rapidly than tri-8:0.

To investigate the role of L-carnitine in medium-chain fatty acid (MCFA, fatty acids with 6-12 carbons) metabolism, 16 newborn pigs were fitted with umbilical arterial catheters. Pigs were placed in respiration chambers, and [1-14C]MCFA were infused for 9-12 h providing energy equivalent to 50-175% of the animals' metabolic rate. After 5-7 h (carnitine-free infusion period) of MCFA infusion, a primed (12.5, 25 or 50 mumol) co-infusion of L-carnitine [5, 10 or 20 mumol/(h.kg0.75), respectively] was started and maintained for 4-5 h (carnitine infusion period). The fatty acid oxidation rate (MCFA-derived CO2/total CO2 x 100) was calculated based on the specific radioactivity of expired CO2 (measured per 20-min interval) and the specific radioactivity of the MCFA infused. A single-pool exponential curve was fitted to the fatty acid oxidation rate of the carnitine-free infusion period and was extrapolated to the carnitine infusion period. For each piglet, the average difference between fatty acid oxidation rate during the carnitine infusion period and the extrapolated curve was calculated and tested for significance using a t test. Under steady state conditions, MCFA oxidation accounted for 40% of MCFA infused. Carnitine, independent of the level, increased the fatty acid oxidation rate by as much as 20% if the energy provided as MCFA exceeded 50% of the metabolic needs of the pig (P < 0.01), and the response above 50% was proportional to the relative rate of fatty acid infusion (increase in fatty acid oxidation rate = -3.9 + 0.07 x infusion rate, r0.76).(ABSTRACT TRUNCATED AT 250 WORDS)

A high-performance liquid chromatographic (HPLC) technique was developed using commercially available derivatization reagents and commonly used reversed-phase HPLC column chemistry to analyze plasma samples for their carnitine ester content. The method proved to be sufficiently sensitive to determine changes in the carnitine ester profile in plasma resulting from metabolic disorders or metabolic insults. The method was tested using plasma samples obtained from pigs fed medium-chain triglycerides (MCT) of different chain lengths (four to seven carbons). The MCT feeding was associated with transient increases in plasma carnitine and carnitine esters, and feeding odd-chain MCT (tri-C5 or tri-C7) led to elevated levels of propionylcarnitine in plasma.